Skip to content
TrialScanner

NCT00679263

Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe Asthma

Phase 2CompletedMNOVLead

Registry record

Lead sponsor
MediciNova
Conditions
Asthma
Primary completion
Jul 2008Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT00679263 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT00679263: Study Evaluating the Safety... | TrialScanner